ライフサイエンスコーパス: vaccination coverage

1 ry 2005 to June 2011) periods, adjusting for vaccination coverage.

2 subsidy policy can in general lead to higher vaccination coverage.

3 ould continue to maintain high routine polio vaccination coverage.

4 hs, taking into account the current level of vaccination coverage.

5 izing patterns of incidence in times of high vaccination coverage.

6 methods for achieving effective anti-rabies vaccination coverage.

7 race or ethnicity; and state-level varicella vaccination coverage.

8 ent and hygiene without a negative impact on vaccination coverage.

9 dependent on several factors including high vaccination coverage.

10 ntervention, measured hygiene indicators and vaccination coverage.

11 tion is high imitation behavior may decrease vaccination coverage.

12 anges in herd immunity due to an increase in vaccination coverage.

13 ions, including noncommunicable diseases and vaccination coverage.

14 and epidemics, even in populations with high vaccination coverage.

15 2001 through 2008 because of sustained high vaccination coverage.

16 munogenicity that could facilitate increased vaccination coverage.

17 act network data were most effective at high vaccination coverage.

18 ethod of administration to improve influenza vaccination coverage.

19 d, and land area negatively associated, with vaccination coverage.

20 ntervention that aimed to increase influenza vaccination coverage.

21 ut timeliness of vaccination than up-to-date vaccination coverage.

22 en subpopulations and that requires only low vaccination coverage.

23 ffected, or even increase, with the level of vaccination coverage.

24 n reported in several countries despite high vaccination coverage.

25 re from Chernobyl, and low routine childhood vaccination coverage.

26 al distribution of TB prevalence and low BCG vaccination coverage.

27 al exemptions can be effective at increasing vaccination coverage.

28 n the two-dose schedule, even with a drop in vaccination coverage.

29 es, especially in countries with high female vaccination coverage.

30 n Lao PDR to estimate the immunogenicity and vaccination coverage.

31 4-month-olds in municipalities with <90% MMR vaccination coverage.

32 nsmission as long as they do not attain high vaccination coverage.

33 hallenging in China despite its high overall vaccination coverage.

34 during the second year of life despite high vaccination coverage.

35 cs, clinical and laboratory evaluations, and vaccination coverage.

36 factors and to optimize childhood pertussis vaccination coverage.

37 In the base-case scenario with 80% vaccination coverage, 35% of all typhoid infections were

38 t-school vaccination significantly increased vaccination coverage (5.50 percentage points [95% CI, 3.

39 Among campaigns with the same vaccination coverage (70% fully vaccinated), the median

40 Different scenarios varied the target vaccination coverage (70-90%), the date these coverages

41 r sample surveys were conducted to determine vaccination coverage achieved.

42 Changes in vaccination coverage across counties after the policy im

43 Review of the historical growth in annual vaccination coverage across countries and regions can be

44 d throughout 2021-2022, the need to maximize vaccination coverage across the United States to minimiz

45 Achieving sufficient worldwide vaccination coverage against SARS-CoV-2 will require add

46 by 10-year moving average of routine measles vaccination coverage (aMCV1).

47 he association between county-wide influenza vaccination coverage among 520 229 younger adults (aged

48 Vaccination coverage among adults aged >/=18 years incre

49 Vaccination coverage among adults under age 65 years inc

50 s highlights the need to improve hepatitis B vaccination coverage among at-risk adults.

51 ffective strategies to increase pneumococcal vaccination coverage among at-risk groups are needed.

52 Between 1997 and 2005, national varicella vaccination coverage among children 19-35 months of age

53 BCG vaccination coverage among children aged 12-23 months wa

54 h the declines in colonization and increased vaccination coverage among children in the age range of

55 During the intervention, influenza vaccination coverage among elementary students was 53%-6

56 Improved vaccination coverage among IDUs has the potential to pre

57 nal tactics that have led to increased polio vaccination coverage among populations living in diverse

58 strategy for achieving and maintaining high vaccination coverage among preschool- and school-aged ch

59 Factor Surveillance System, they considered vaccination coverage among those non-Hispanic Whites, no

60 Eliminating health disparities in vaccination coverage among various groups is a cornersto

61 Increasing influenza vaccination coverage among young children and pregnant w

62 caled up over the period 2020-50 (eg, 20-45% vaccination coverage and 25-70% once-per-lifetime screen

63 ening coverage by 2030, increasing to 40-90% vaccination coverage and 90% once-per-lifetime screening

64 eliminated in the United States through high vaccination coverage and a public health system able to

65 was associated with an estimated increase in vaccination coverage and a reduction in nonmedical exemp

66 ion in major urban centers with insufficient vaccination coverage and abundant populations of the dom

67 Sustained vaccination coverage and clinical and environmental surv

68 mmunity, underscoring the importance of high vaccination coverage and containment in limiting measles

69 High vaccination coverage and control measures likely limited

70 tation behavior and contact heterogeneity on vaccination coverage and disease dynamics.

71 The analysis used population-based vaccination coverage and disease incidence data to make

72 analysis was conducted with population-based vaccination coverage and disease incidence data.

73 has been proposed as one strategy to improve vaccination coverage and disease prevention.

74 ne the dose-response association between HPV vaccination coverage and each study effect measure.

75 77/case averted in Puerto Rico, varying with vaccination coverage and efficacy (societal perspective)

76 the county was examined by comparing measles vaccination coverage and epidemiology before (1985-1987)

77 Measurement of vaccination coverage and feedback to providers.

78 tween the estimates obtained for the current vaccination coverage and for a hypothetical scenario exc

79 Despite high regional vaccination coverage and functioning surveillance, sever

80 Under base-case assumptions, 40% vaccination coverage and girls-only vaccination, the RRp

81 n living in the United States may have lower vaccination coverage and greater lifetime exposure to he

82 d the importance of spatial heterogeneity in vaccination coverage and human-mediated dog movements fo

83 Improvement in routine childhood vaccination coverage and implementation of mass adult va

84 sources, including personnel, for increasing vaccination coverage and improved performance monitoring

85 eve and sustain high routine measles-rubella vaccination coverage and maintain high-quality integrate

86 the impact of the 2016 California policy on vaccination coverage and prevalence of exemptions to vac

87 eted efforts are needed to improve influenza vaccination coverage and reduce disparities.

88 population immunity as estimated by national vaccination coverage and serologic surveys.

89 d findings was low, but increased with lower vaccination coverage and shorter vaccine protection (fro

90 veys, we determined the relationship between vaccination coverage and the probability of dying betwee

91 r baseline cross-reactive antibody, pandemic vaccination coverage and the sensitivity/specificity of

92 These restrictions could adversely impact vaccination coverage and thereby its health impact, part

93 On the basis of current vaccination coverage and timing, rotavirus vaccination w

94 ation studies were conducted to estimate the vaccination coverage and to measure the impact of vaccin

95 l to provide fast and accurate assessment of vaccination coverage and vaccination gaps to make strate

96 on efforts include demonstration of the high vaccination coverage and, in turn, population immunity n

97 n of schools below a high-risk threshold for vaccination coverage, and five-year trends in CVEs.

98 nce to improve measles surveillance, routine vaccination coverage, and outbreak investigation and res

99 PsA-TT implementation achieved high vaccination coverage, and results from studies conducted

100 onomic factors, demographic characteristics, vaccination coverage, and the estimated proportion of ch

101 rogression rates after infection, historical vaccination coverage, and vaccine efficacy.

102 comparing studies according to vaccine type, vaccination coverage, and years since implementation of

103 accinated children may occur in schools with vaccination coverage approaching 50%.

104 rculation in most of the world and imperfect vaccination coverage are resulting in immunity gaps and

105 ds used include house-to-house monitoring of vaccination coverage as a supervisory tool during both c

106 In maternal cohorts with 60%-80% HPV vaccination coverage as achieved in Australia, there was

107 rth year, maternal age, and age-specific HPV vaccination coverage as independent variables.

108 In the future, further vaccination coverage, as well as improved influenza vacc

109 We estimated vaccination coverage at different ages, and delays in ad

110 on; the importance of accurate monitoring of vaccination coverage at local, state, and national level

111 man resources for health as a determinant of vaccination coverage at the population level has not bee

112 stically significant differences in rates of vaccination coverage between Whites and members of other

113 Sustained emphasis on improvement of vaccination coverage, birth hygiene, and surveillance, w

114 t of infection, imitation behavior increases vaccination coverage, but, surprisingly, also increases

115 We compared vaccination coverage by race/ethnicity within each age a

116 Disparities in vaccination coverage by racial/ethnic composition were s

117 rict of Columbia (DC) and compared varicella vaccination coverage by state to year of implementation

118 Differences in vaccination coverage can perpetuate coronavirus disease

119 lts highlight important gaps in yellow fever vaccination coverage, can contribute to improved quantif

120 these trends were compared to changes in HPV vaccination coverage, cervical cancer screening, an ante

121 to consider possible explanations including vaccination coverage, changes in screening for cervical

122 ctly protected in the school with nearly 50% vaccination coverage compared with control schools (infl

123 nfection of transport vehicles twice a week, vaccination coverage could be lowered to 60% in the best

124 formation campaigns are prevalent, affecting vaccination coverage, creating uncertainty in election r

125 Outcomes were assessed through vaccination coverage data and more qualitative measures.

126 Seroprevalence and vaccination coverage data indicate high levels of popula

127 re defined through the real-time analysis of vaccination coverage data, this approach resulted in the

128 seroprevalence data from Belgium and Belgian vaccination coverage data.

129 This can be estimated from vaccination coverage data.

130 ta from the most highly affected states, and vaccination-coverage data from three nationwide surveys.

131 Vaccination coverage decreased during 2006-11 in the Fed

132 that, under the partial-subsidy policy, the vaccination coverage depends monotonically on the sensit

133 Influenza vaccination coverage derived from data from the Centers

134 n on SIAs, measles surveillance, and routine vaccination coverage during 2000-2009.

135 data on national measles-mumps-rubella (MMR) vaccination coverage during postelimination years 2001-2

136 To improve vaccination coverage estimates based on surveys, we reco

137 To provide vaccination coverage estimates for the 12-zone area, we

138 he post-Ebola virus disease outbreak period, vaccination coverage for polio, measles, and yellow feve

139 llingness to pay for life-years, the optimal vaccination coverage for Serengeti was 70%.

140 In China, where countrywide vaccination coverage for the last decade has been above

141 Declines in vaccination coverage for vaccine-preventable diseases, s

142 s study were to estimate global yellow fever vaccination coverage from 1970 through to 2016 at high s

143 We reviewed national vaccination coverage from 1992 through 2008.

144 e found that a sustained decrease in measles vaccination coverage from 91.9% (2013 level) to 90.0% (2

145 Monte Carlo methods to estimate variation in vaccination coverage from children's vaccination histori

146 was calculated on the basis of estimates of vaccination coverage from data for non-polio acute flacc

147 n 2000 or earlier was associated with higher vaccination coverage (> or =90%; P=.002).

148 Vaccination coverage (>95%) and immunity (approximately

149 ammes with multi-cohort vaccination and high vaccination coverage had a greater direct impact and her

150 wever, the public health efforts to increase vaccination coverage has resulted in earlier administrat

151 ated that children in clusters with complete vaccination coverage have a relative risk of mortality t

152 ehold surveys that are often used to measure vaccination coverage have invested substantial effort to

153 f children younger than 5 years despite high vaccination coverage, improved nutrition, and widespread

154 ng indigenous transmission through efficient vaccination coverage in at-risk subpopulations and among

155 ntion were used to simulate county-level MMR vaccination coverage in children (age 2-11 years) in the

156 orkers can be a major constraining factor on vaccination coverage in developing countries.

157 ity was positively associated with childhood vaccination coverage in developing countries.

158 for self-administration can expand influenza vaccination coverage in developing countries.

159 ent study were to assess trends in influenza vaccination coverage in HIV-infected patients and to det

160 Levels of measles-vaccination coverage in Indiana were 92 percent for pres

161 association of the 1883 vaccination law with vaccination coverage in infants (age <1 year) across dif

162 The measurement of vaccination coverage in low- and middle-income countries

163 ent during vaccination campaigns and improve vaccination coverage in noncompliant communities.

164 However, decreases in vaccination coverage in parts of Pakistan and southern A

165 This is important, as pneumococcal vaccination coverage in PLWH is low in Europe and the Un

166 Overall vaccination coverage in the population sampled was 89.7%

167 Routine (keep-up) vaccination coverage in the Region increased from 80% in

168 Although influenza vaccination coverage in this population has increased in

169 logistic regression models by comparing the vaccination coverage in those who tested positive for in

170 p and follow-up mass campaigns achieved high vaccination coverages in the respective targeted age gro

171 cases reported in districts with lower local vaccination coverage (incidence rate ratio IRR = 1.45 (9

172 Maintenance of high rates of vaccination coverage, including improved strategies of c

173 In the county-level analysis, overall vaccination coverage increased by 4.3% (95% confidence i

174 Between 1990 and 2022, BCG vaccination coverage increased by at least 25% in 85.32%

175 Regional vaccination coverage increased during the period 1987-20

176 vaccine was introduced in 1977, and measles vaccination coverage increased from <50% to >90% from 19

177 Vaccination coverage increased from 28.5% in the 1990 to

178 Vaccination coverage increased in urban areas.

179 piratory syndrome coronavirus 2 (SARS-CoV-2) vaccination coverage increases in the United States, the

180 2) Delta variant outbreak despite high (99%) vaccination coverage, indoor masking policies, and twice

181 Scale-up of vaccination coverage, innovations in scalable options fo

182 yping of viral isolates, surveys of rates of vaccination coverage, interviews regarding attitudes tow

183 ough (pertussis) in many countries with high vaccination coverage is alarming.

184 Vaccination coverage is an important public health indic

185 Accurately quantifying vaccination coverage is complicated by limited individua

186 V infection is not well known, while the HPV vaccination coverage is low in the United States.

187 effective TBEV vaccines have been approved, vaccination coverage is low, and due to the lack of spec

188 ead among all age groups of men, and the HPV vaccination coverage is low.

189 entrated in sectors of the populations whose vaccination coverage is lower than the average.

190 or one-sided interactions, sufficiently high vaccination coverage is necessary for mitigating the eff

191 In many endemic countries, a 90% vaccination coverage is needed to achieve elimination.

192 n PEH blood-transmitted virus prevalence and vaccination coverage is needed to design targeted interv

193 If routine measles-rubella vaccination coverage is suboptimal or if gaps in coverag

194 Sustained high vaccination coverage is the key to preventing measles de

195 large outbreaks in the United States, where vaccination coverage is very high.

196 es vaccination campaign, maintenance of high vaccination coverage (keep-up), and periodic follow-up m

197 c was associated with important increases in vaccination coverage levels and a reduction in the propo

198 ensitivity analyses to account for rotavirus vaccination coverage levels and sites that collected spe

199 It is important to note that influenza vaccination coverage levels overall and in this populati

200 transmission intensity can be combined with vaccination coverage levels to evaluate the impact of pa

201 e also tested the effectiveness of different vaccination coverage levels.

202 asles and rubella; and measles-mumps-rubella vaccination coverage levels.

203 First, elimination requires very high vaccination-coverage levels by age 2 years.

204 In countries with female vaccination coverage lower than 50%, significant reducti

205 risk of HIV, we suggest that increasing HPV vaccination coverage may carry an additional benefit of

206 The vaccination coverage necessary to reduce CRS depends on

207 ng and informing public health responses and vaccination coverage needed to address the ongoing sprea

208 We showed that vaccination coverage needed to eliminate YF epidemics in

209 A marked increase in vaccination coverage occurred in Georgia public clinics

210 d levels had the same mitigating effect as a vaccination coverage of 50% to 60%.

211 Achieving an influenza-like vaccination coverage of 66% for the population of older

212 e predict that countries maintaining routine vaccination coverage of 80% or higher are can be confide

213 Despite varicella vaccination coverage of 80%, a sizeable outbreak occurre

214 pite achieving and sustaining global measles vaccination coverage of about 80% over the past decade,

215 In countries with female vaccination coverage of at least 50%, HPV type 16 and 18

216 In 1988, vaccination coverage of children 24 months of age in the

217 reflecting demographic contexts and measles vaccination coverage of four heterogeneous countries: Ne

218 s our three models and suggest that high HPV vaccination coverage of girls can lead to cervical cance

219 Vaccination coverage of nomadic children 0-59 months of

220 Initiative partners, took steps to increase vaccination coverage of nomadic children with targeted p

221 The vaccination coverage of the study cohort ranged from 16%

222 the importance of maintaining high levels of vaccination coverage once the vaccine is introduced.

223 e heterogeneity in immunity, due to previous vaccination coverage or infection, may lead to potential

224 Despite low vaccination coverage, pediatric COVID-19 immunization in

225 ge of all PCR tests that were positive), and vaccination coverage (percentage of county population th

226 expansion of the disease and recent gains in vaccination coverage, pre-existing immunity to dengue vi

227 As vaccination coverage progresses in countries, relaxation

228 cts primarily from self-interest, as greater vaccination coverage provides no personal utility to the

229 Measles vaccination coverage ranged between 75% and 99% in 2000

230 Measles-mumps-rubella dose 1 vaccination coverage ranged from 97% to 99%.

231 Vaccination coverage ranging from 0% to 95% in increment

232 valence of genital HPV infection and the HPV vaccination coverage rate among adult men.

233 vaccination, eventually reducing the overall vaccination coverage rate and vaccine effectiveness.

234 ve age (n = 24216), the reported hepatitis B vaccination coverage rate was 33% lower for foreign-born

235 influenza vaccine recommendation in the US, vaccination coverage rates (VCR) in working-age adults (

236 ovascular disease can help improve influenza vaccination coverage rates by providing and strongly rec

237 Childhood vaccination coverage rates for the basic vaccines from t

238 Vaccination coverage rates ranged between 41.9% for neon

239 be done by providers and parents to increase vaccination coverage rates to better protect children an

240 -specific diphtheria, tetanus, and pertussus vaccination coverage rates to estimate rotavirus vaccine

241 d by 80% in 1 active surveillance area where vaccination coverage reached 90.5% in 2006.

242 Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with h

243 oversial, and their effectiveness to improve vaccination coverage remains unclear given limited rigor

244 ay significantly underestimate the levels of vaccination coverage required to attain herd immunity.

245 leakiness is concerning because it increases vaccination coverage required to prevent disease spread

246 HZ incidence did not vary by state varicella vaccination coverage (RR, 0.9998 [CI, 0.9993 to 1.0003])

247 ission model with realistic dog movement and vaccination coverage scenarios, assuming a basic reprodu

248 ed intervention impacts on student influenza vaccination coverage, school absenteeism, and community-

249 s encephalitis was infrequent following high vaccination coverage since 2007.

250 en November 1996 and June 1998, despite high vaccination coverage since the early 1980s.

251 derately high background levels of influenza vaccination coverage, SLIV programs are associated with

252 overnmental incentives to achieve widespread vaccination coverage so as to prevent epidemic outbreak?

253 ngthen immunization programs to achieve high vaccination coverage; some must undertake strategies to

254 ied survival analysis methods to data from a vaccination coverage survey among children aged 13-59 mo

255 , since populations likely to be missed in a vaccination coverage survey are also likely to be missed

256 We conducted a cross-sectional serologic and vaccination coverage survey in Nayapara Registered Refug

257 Despite high vaccination coverage, sustained measles transmission occ

258 s not possible to maintain annual, intensive vaccination coverage, the duration and breadth of immuni

259 With 80% girls-only vaccination coverage, the RRprev of HPV 16 among women a

260 stem utilization with influenza illness, and vaccination coverage through active community-based surv

261 ly heavily on achieving and maintaining high vaccination coverage through the routine immunization ac

262 ata with demographic information and tracked vaccination coverage through time to estimate the propor

263 nd emphasizes the importance of high measles vaccination coverage throughout the population.

264 all four OPVs in use and combined this with vaccination coverage to estimate the effect of the intro

265 tbreak underscores the need to maintain high vaccination coverage to prevent outbreaks, the need to m

266 This reinforces the need for high vaccination coverage to protect vaccinated individuals a

267 This reemphasizes the need for high measles vaccination coverage to support population-level immunit

268 y, we propose a design to estimate rotavirus vaccination coverage using controls from a rotavirus VE

269 We did sensitivity analyses by varying vaccination coverage, vaccine efficacy, and duration of

270 Currently, in communities with high vaccination coverage, varicella cases mostly occur in va

271 Vaccination coverage varied in a curvilinear fashion wit

272 COVID-19 vaccination coverage varied substantially by SVI.

273 We considered scenarios that achieved 80% vaccination coverage, various starts of vaccination prog

274 re hindered by challenges in sustaining high vaccination coverage, waning immunity in HIV-1-infected

275 COVID-19 vaccination coverage was 0.75 times (95% confidence inte

276 Among vaccine-eligible men, the HPV vaccination coverage was 10.7% (95% CI, 7.8%-14.6%).

277 Based on 11 studies, the full vaccination coverage was 21% (95% CI, 11%-36%; I2 = 98.9

278 A 10% improvement in vaccination coverage was associated with an 8% (95% conf

279 When the vaccination coverage was constrained to exceed 95% or 90

280 BCG vaccination coverage was defined as the number of childr

281 Census-level vaccination coverage was estimated as proportion of age-

282 During seasons when vaccination coverage was higher among intervention schoo

283 Vaccination coverage was low for women who were born in

284 Associations among the testing metrics and vaccination coverage were estimated using multiple linea

285 population density, forest cover and routine vaccination coverage were the strongest predictors of po

286 ng efforts to improve birth dose and newborn vaccination coverage, will be cost-saving and can genera

287 Among those aged 2 years, vaccination coverage with > or =1 dose increased from 75

288 Measles-mumps-rubella (MMR) vaccination coverage with at least a single dose was est

289 by Bordetella pertussis Despite wide global vaccination coverage with efficacious pertussis vaccines

290 poliovirus eradication efforts include high vaccination coverage with live oral polio vaccine (OPV),

291 with the nonavalent vaccine and assumed 80% vaccination coverage with one or two doses.

292 PV type 1 (WPV1) in April 2013, despite high vaccination coverage with only inactivated poliovirus va

293 it is necessary to achieve and maintain high vaccination coverage with three or more doses of diphthe

294 increased after relaxing constraints on the vaccination coverage, with best-fitting values of 83% (9

295 emphasis should be placed on achieving high vaccination coverage, with special efforts to vaccinate

296 In 12 zones with low vaccination coverage within Kinshasa Province, Democrati

297 It is important to improve vaccination coverage within the adolescent age group.

298 model simulations suggested that increasing vaccination coverage would decrease the total number of

299 At a national level, 46% vaccination coverage would result in an (R(0)) <1, which

300 However, after a period of low vaccination coverage, yellow fever has resurged in the c